Rush Cancer Institute — Chicago, Illinois

Rush Cancer Institute is a clinical research site located in Chicago, Illinois, United States 60612.

Crixeo Clinical Trials Trust Score: 19/100 (FAILING). This profile has not yet been claimed by the site owner.

Rush Cancer Institute has participated in 13 clinical trials.

Therapeutic areas: Leukemia, Colorectal Carcinoma, Meningeal Neoplasms.

Sponsors: Rush University Medical Center, Millennium Pharmaceuticals, Inc., Pacira Pharmaceuticals, Inc.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Chicago

Browse all research sites in Illinois · View every site in Chicago

Sponsor Feasibility Report

Trust Score: 19/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rush Cancer Institute?

Rush Cancer Institute has a Crixeo Trust Score of 19/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rush Cancer Institute conducted?

Rush Cancer Institute has 13 clinical trials on record. Their work covers Leukemia, Colorectal Carcinoma, Meningeal Neoplasms.

Is Rush Cancer Institute accredited by Crixeo Clinical Trials?

Rush Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rush Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.